We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Modifying the Macrophage Microenvironment Reduces Tuberculosis Virulence

By LabMedica International staff writers
Posted on 05 Aug 2015
Print article
Image: Mycobacterium tuberculosis (Mtb) uses environmental pH as a cue to adapt its physiology for survival in macrophages. The phoPR two-component regulatory system functions to sense environmental pH and promote Mtb pathogenesis (Photo courtesy of Michigan State University).
Image: Mycobacterium tuberculosis (Mtb) uses environmental pH as a cue to adapt its physiology for survival in macrophages. The phoPR two-component regulatory system functions to sense environmental pH and promote Mtb pathogenesis (Photo courtesy of Michigan State University).
The virulence of the bacteria causing latent tuberculosis infections can be reduced by modifying the microenvironment inside the macrophages that host the pathogen.

Mycobacterium tuberculosis must sense and adapt to host environmental cues to establish and maintain an infection. The two-component regulatory system PhoPR plays a central role in sensing and responding to acidic pH within the macrophage and is required for M. tuberculosis intracellular replication and growth in vivo. Therefore, the isolation of compounds that inhibit PhoPR-dependent adaptation may pave the way for development of new therapies to treat tuberculosis.

Investigators at Michigan State University (East Lansing, USA) screened more than 273,000 different compounds while searching for those that could attenuate or eradicate M. tuberculosis.

They identified the carbonic anhydrase inhibitor ethoxzolamide as being able to modify PhoPR regulation and reduce virulence of the tuberculosis bacterium. Ethoxzolamide binds and inhibits carbonic anhydrase, which plays an essential role in facilitating the transport of carbon dioxide and protons in the intracellular space, across biological membranes and in the layers of the extracellular space. The primary function of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The inhibition of this enzyme affects the balance of applicable membrane equilibrium systems. Carbonic anhydrase inhibitors are primarily used for the treatment of glaucoma. They may also be used to treat seizure disorder and acute mountain sickness. Because they encourage solubilization and excretion of uric acid, they can be used in the treatment of gout.

The investigators reported in the August 2015 issue of the journal Antimicrobial Agents and Chemotherapy that by employing quantitative single-cell imaging of a PhoPR-dependent fluorescent reporter M. tuberculosis strain, they were able to demonstrate that ethoxzolamide inhibited PhoPR-regulated genes in infected macrophages and mouse lungs. Moreover, ethoxzolamide reduced M. tuberculosis growth in both macrophages and infected mice.

"The compound we found inhibits TB's ability to detect acidic environments, effectively blindfolding the bacterium so it cannot resist the immune system's assault," said senior author Dr. Robert Abramovitch, assistant professor of microbiology at Michigan State University. "Basically, ethoxzolamide stops TB from deploying its weapons...shutting down its ability to grow inside certain white blood cells in the immune system. We found the compound reduces disease symptoms in mice."

"The single biggest reason for the evolution of drug-resistant strains is the long course of treatment," said Dr. Abramovitch. "It is difficult for a patient to complete the entire antibiotic course required to kill all of the bacteria. Shortening the duration will help slow the development of these resistant strains. We do not necessarily have to find drugs that kill TB, we just need to find ones that interfere with the bug's ability to sense and resist the immune system. By giving the immune system a helping hand, natural defenses can then kill the bacteria."

Related Links:

Michigan State University


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
Urine Collection Container
Urine Monovette
New
ELISA System
ABSOL HS DUO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.